Recent progress on the Ada response for inducible repair of DNA alkylation damage.
Sedgwick
Barbara
B
Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Hertfordshire EN6 3LD, UK.
Lindahl
Tomas
T
D000222:Adaptation, Physiological / Q000187:drug effects; D000477:Alkylating Agents / Q000494:pharmacology*; D000595:Amino Acid Sequence; D018407:Bacterial Physiological Phenomena; D001426:Bacterial Proteins / Q000187:drug effects / Q000235:genetics / Q000378:metabolism*; D004249:DNA Damage / Q000187:drug effects* / Q000235:genetics; D045647:DNA Glycosylases; D019175:DNA Methylation; D004260:DNA Repair / Q000187:drug effects / Q000502:physiology*; D029968:Escherichia coli Proteins; D006899:Mixed Function Oxygenases; D008969:Molecular Sequence Data; D009699:N-Glycosyl Hydrolases / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D019853:O(6)-Methylguanine-DNA Methyltransferase; D017386:Sequence Homology, Amino Acid; D014157:Transcription Factors
C090096:AidB protein, E coli; D000477:Alkylating Agents; D001426:Bacterial Proteins; D029968:Escherichia coli Proteins; D014157:Transcription Factors; D006899:Mixed Function Oxygenases; C466427:AlkB protein, E coli; C045675:Ada protein, E coli; D019853:O(6)-Methylguanine-DNA Methyltransferase; D045647:DNA Glycosylases; D009699:N-Glycosyl Hydrolases; C076131:DNA-3-methyladenine glycosidase II